€38.96
0.10% today
Amsterdam, Sep 03, 11:15 am CET
ISIN
NL0006144495
Symbol
REN
Index
AEX

RELX Stock price

€38.92
-6.04 13.43% 1M
-7.52 16.19% 6M
-4.80 10.98% YTD
-3.26 7.73% 1Y
+12.93 49.75% 3Y
+19.50 100.41% 5Y
+25.52 190.34% 10Y
+30.35 354.15% 20Y
Amsterdam, Closing price Tue, Sep 02 2025
-0.72 1.82%
ISIN
NL0006144495
Symbol
REN
Index
AEX

Key metrics

Basic
Market capitalization
€72.0b
Enterprise Value
€80.5b
Net debt
€8.4b
Cash
€242.8m
Shares outstanding
1.8b
Valuation (TTM | estimate)
P/E
32.7 | 25.6
P/S
6.6 | 6.2
EV/Sales
7.3 | 7.0
EV/FCF
31.0
P/B
28.7
Dividends
DPS
€0.76
Yield 1Y | 5Y
2.0% | 2.0%
Growth 1Y | 5Y
7.7% | 8.1%
Payout 1Y | 3Y
59.1% | 60.3%
Increased
6 Years
Financials (TTM | estimate)
Revenue
€11.0b | €11.5b
EBITDA
€4.2b | €4.7b
EBIT
€3.3b | €4.0b
Net Income
€2.2b | €2.8b
Free Cash Flow
€2.6b
Growth (TTM | estimate)
Revenue
2.5% | 6.2%
EBITDA
2.8% | 32.3%
EBIT
4.2% | 24.2%
Net Income
1.7% | 25.1%
Free Cash Flow
9.8%
Margin (TTM | estimate)
Gross
65.5%
EBITDA
38.3% | 40.6%
EBIT
30.2%
Net
20.2% | 24.2%
Free Cash Flow
23.7%
Financial Health
Equity Ratio
23.0%
Return on Equity
55.6%
ROCE
33.6%
ROIC
21.3%
Debt/Equity
3.5
More
EPS
€1.2
FCF per Share
€1.4
Short interest
-
Employees
35k
Rev per Employee
€310.0k
Show more

Is RELX a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

RELX Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a RELX forecast:

20x Buy
83%
4x Hold
17%

Analyst Opinions

24 Analysts have issued a RELX forecast:

Buy
83%
Hold
17%

Financial data from RELX

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
10,970 10,970
2% 2%
100%
- Direct Costs 3,787 3,787
2% 2%
35%
7,183 7,183
3% 3%
65%
- Selling and Administrative Expenses 3,874 3,874
2% 2%
35%
- Research and Development Expense - -
-
-
4,198 4,198
3% 3%
38%
- Depreciation and Amortization 889 889
2% 2%
8%
EBIT (Operating Income) EBIT 3,309 3,309
4% 4%
30%
Net Profit 2,215 2,215
2% 2%
20%

In millions EUR.

Don't miss a Thing! We will send you all news about RELX directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity. The Risk & Business Analytics segment provides customers with solutions and decision tools that combine public and industry specific content with advanced technology and analytics to assist them in evaluating and predicting risk and enhancing operational efficiency. The Legal segment is a global provider of legal, regulatory and business information and analytics that helps customers increase productivity, improve decision-making and outcomes and advance the rule of law around the world. The Exhibitions segment is an event business, enhancing the effect of face-to-face through data and digital tools. The company was founded by Albert Edward Reed in 1894 and is headquartered in London, the United Kingdom.

Head office Netherlands
CEO Erik Engstrom
Employees 35,490
Founded 1903
Website www.relx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today